ANTHRASIL

This brand name is authorized in United States.

Active ingredients

The drug ANTHRASIL contains one active pharmaceutical ingredient (API):

1
UNII VKZ83S945Z - ANTHRAX IMMUNE GLOBULIN HUMAN
 

Anthrax immuneglobulin is a human immune globulin that is used in combination with antibiotics to treat anthrax. Anthrax immunoglobulin binds to protective antigen (PA) to prevent PA mediated cellular entry of anthrax edema factor and lethal factor.
 
Read more about Anthrax immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ANTHRASIL Solution for infusion MPI, US: SPL/PLR FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
US FDA, National Drug Code 60492-0249

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈